Points patients toward the treatment options and expertise most likely to fit their disease profile.
Consented intake · your records travel with you · nothing moves without your sign-off
MediFind supports biomarker-drug matching for cancer patients. Based on the disease profile in a patient's test data, it helps recommend treatment options with the most likely effective response, predict treatment response, and assess confidence in the outcome. It is for patients who want their next treatment decision informed by the best available global thinking.
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how MediFind handles billing.
We don't have confirmed insurance details for MediFind yet. Start a coverage check with your plan, or contact the provider directly.
Answers grounded in MediFind's details here. Educational only; your oncologist directs treatment.
Ask OpenCancer · answers grounded in this storefront
Other providers in similar categories.
Provide a trusted medical context for personalized experiments; contribute to research that will benefit others and hope that new treatments will be identified in time that may help me.
Find the best advice in the world, geographically, willing to treat outside the standard of care, appropriately aggressive
FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
This page is general information. Upload your records for analysis specific to YOUR diagnosis.